A genetically engineered vaccine eradicated high-grade precancerous cervical lesions in almost half of women participating in a clinical trial at Johns Hopkins University in the US.
Not to be confused with preventative vaccines such as Gardasil, the new treatment could provide a nonsurgical solution for existing precancerous lesions caused by the human papillomavirus (HPV) that's typically spread through sexual contact.
"Every standard therapeutic option for women with these lesions destroys part of the cervix," says first author Cornelia Trimble, M.D. of Johns Hopkins, "Which is particularly relevant for women of childbearing age, who may then be at risk for preterm birth due to a weakened cervix."
Women aged 40 or younger are the most likely to develop high-grade cervical lesions, and existing solutions are invasive and include surgery, freezing or laser treatment, says Dr. Trimble.
Less threatening lesions -- referred to as low-grade dysplasia -- do not require immediate removal, but doctors monitor them in the hopes they will regress, because until they do, they still pose some degree of risk.
The brainchild of University of Pennsylvania scientist David Weiner, PhD, the vaccine is designed to instill recognition of precancerous and cancerous cells in the immune system.
The research team spent two years recruiting 167 women between the ages of 18 and 55, all of whom were newly diagnosed with high-grade precancerous cervical lesions.
When recruiting was complete in 2013, the women received either three doses of the vaccine or placebo injections over the course of 12 weeks across 36 hospitals and private gynecology practices in the US and six additional countries.
Following each injection, the women were given a small electric pulse at the injection site, causing cells in the vicinity to open their pores and thereby increasing the chances of the vaccine being picked up by the immune system.
55, or 48.2 percent of the 114 women who received at least one dose saw their lesions regress or convert to low-grade dysplasia, according to the paper.
For the 107 women who received all three injections, HPV was subsequently undetectable in 56 of them, say the researchers.
"In many of these women, the vaccine not only made their lesions disappear, but it also cleared the virus from their cervix," says Dr. Trimble. "In most unvaccinated patients whose lesions went away, the virus was still present, and many still had low-grade lesions."
Meanwhile, 12, or 30 percent of the 40 women given at least one placebo injection experienced regression or conversion of their lesions.
36 of these women received all three placebo doses and 11 of them, or 30.6 percent saw their lesions regress.
The vaccine is made by Inovio Pharmaceuticals, Inc., who funded the trial and whose employees co-authored Dr. Trimble's paper, published in the Lancet.
AFP RELAXNEWS
Sun Sep 20 2015
A new vaccine is looking promising as a nonsurgical treatment for existing precancerous and cancerous cervical lesions. - AFP Photo
Terdapat keperluan tambah bilangan wanita isi jawatan KSU, KP - PM Anwar
Anwar berkata jumlah pimpinan wanita sedia ada tidak mencerminkan jumlah keseluruhan 42 peratus golongan itu yang terlibat sebagai pembuat keputusan dalam perkhidmatan awam ketika ini.
Norjuma didakwa atas lima tuduhan cedera, khianat
Bekas personaliti televisyen Norjuma Habib Mohamed didakwa atas tiga pertuduhan menyebabkan kecederaan ke atas tiga individu dan dua pertuduhan melakukan khianat.
Pegawai kanan polis lindungi sindiket haram diarah isytihar harta - Azam Baki
Suruhanjaya Pencegahan Rasuah Malaysia (SPRM) telah memberikan notis pengisytiharan harta, dengan tarikh akhir pada 28 April ini, kepada pegawai kanan polis yang ditahan kerana disyaki melindungi sind
Malaysia, Jepun perkukuh kerjasama strategik dalam sektor binaan - Nanta
Kerajaan Malaysia dan Jepun memperkukuhkan kerjasama strategik dalam sektor teknologi dan digitalisasi pembinaan, infrastruktur jalan, pengurusan bencana dan cerun.
Bangkai, serpihan helikopter terhempas dibawa keluar dari lokasi nahas
Operasi membawa keluar bangkai dan serpihan pesawat HOM (M503-3) dan Fennec (M502-6) itu dimulakan pada jam 9 pagi pada Khamis dan selesai sekitar jam 4.30 petang tadi.
MOT cadang perkenal perkhidmatan komuter sokong RTS Link
Kementerian Pengangkutan bercadang memperkenalkan perkhidmatan komuter bagi menyokong projek RTS Link yang akan beroperasi sepenuhnya pada 1 Jan 2027.
Niaga AWANI: Meta turunkan jangkaan untuk hasil suku kedua
Meta meramalkan pendapatan suku kedua mungkin berada di bawah jangkaan pasaran, menandakan kemungkinan semakan mengenai teknologi AI baharu yang boleh meningkatkan perniagaan syarikat.
#NiagaAWANI
#NiagaAWANI
Niaga AWANI: Dunia siber yang selamat perlu input wanita - Nurul Izzah
Nurul Izzah berkata, sasaran dunia siber yang lebih selamat memerlukan input daripada wanita untuk memahami cara bagi membolehkan ekosistem selamat diwujudkan.
#NiagaAWANI
#NiagaAWANI
Niaga AWANI: Chongqing percepat usaha jadi hab utama barat daya China
Hab logistik di Chongqing memainkan peranan penting dalam membina zon ekonomi Chengdu-Chongqing, dan mewujudkan kawasan hab kawasan pedalaman yang terkemuka.
#NiagaAWANI
#NiagaAWANI
Niaga AWANI: MRANTI pertingkat kerjasama bidang teknologi, inovasi
Antara lima bidang utama kerjasama tersebut meliputi pertukaran kakitangan dan perkongsian pengalaman pembangunan.
#NiagaAWANI
#NiagaAWANI